Jan 7 (Reuters) - ALLOY THERAPEUTICS:
ALLOY THERAPEUTICS: ANNOUNCES A TARGET SPECIFIC COLLABORATION & LICENSE AGREEMENT FOR USE OF ANTICLASTIC ANTISENSE PLATFORM WITH SANOFI
ALLOY THERAPEUTICS: SANOFI TO PROVIDE ALLOY WITH UPFRONT LICENSE FEES & NEAR-TERM PRECLINICAL MILESTONE PAYMENTS UP TO $27.5 MILLION
ALLOY THERAPEUTICS: UNDER AGREEMENT, ALLOY ALSO ELIGIBLE TO RECEIVE DISCOVERY, DEVELOPMENT, AND COMMERCIAL MILESTONE PAYMENTS OF OVER $400 MILLION
Source text: ID:nBw3F9qb7a
Further company coverage: SASY.PA
((Reuters.Briefs@thomsonreuters.com;))